The effectiveness of modern chondroprotective therapy in patients with degenerative-dystrophic diseases of the spine associated with pain in the lower back

An observational study of the effectiveness of the injectable Symptomatic Slow-Acting Drugs (SYSADOA) having chondroprotective activity was conducted in the amount of 10 injections, 1 injection of 2 ml every other day for 20 days. The study included 30 patients aged 40 to 65 years suffering from low back pain caused by degenerative-dystrophic diseases of the spine. Analysis of the results showed that therapy is effective in non-specific musculoskeletal low back pain at the prescribed dose: after 20 days of therapy of the low back pain in the studied group of patients decreased statistically significantly: from 70.1 ± 10.03 to 17.47 ± 8.94 on a 100-point visual-analog scale (p < 0.05); the average indicator of health status increased from 37.03 ± 14.49 to 87.6 ± 8.93, respectively (p < 0.05). Positive dynamics after 20 days of treatment was observed in all categories of the European Quality of Life Questionnaire (EQ-5D), health levels improved statistically significantly from the beginning to the end of the course of therapy (p < 0.05). According to the indicators of 100-point satisfaction with treatment, on average, patients were satisfied with therapy by 93.9 ± 5.97 points out of 100. Chondroprotective therapy made it possible to reduce the need for non-steroid anti-inflammatory drugs in patients, reduce their dose or do without non-steroid anti-inflammatory drugs during the course of treatment. Due to the convenient dosing regimen and rapid therapeutic effect, all patients demonstrated high compliance and completed the study according to plan. Thus, the proposed treatment regimen can be recommended for patients with pain syndrome in the lower back caused by degenerative-dystrophic diseases of the spine.

1. Vyortkin A. L., SHamuilova M. M., Knorring G. Yu., et al. Prevention and treatment of back pain: expert consensus // Doktor.Ru. 2020; 19 (9): 45-52. DOI: 10.31550/1727-23782020-19-9-45-52.]

2. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 // Lancet. 2015; 386: 743-800.

3. Yakhno N. N., Kukushkin M. L. Chronic pain: biomedical and socio-economic aspects // Vestnik Rossiyskoy akademii meditsinskikh nauk. 2012; 9: 54-58.

4. Podchufarova Ye. V., Yakhno N. N., Alekseyev V. V., Avedisova A. S., Chakhava K. O., Yershova Ye. M., et al. Chronic pain syndromes of the lumbosacral localization: the significance of structural skeletal muscle disorders and psychological factors // Bol'. 2003; 1: 38-43.]

5. Norasteh Ali Asghar. Low Back Pain / Edited by Ali Asghar Norasteh. ISBN 13: 9789535105992, In Tech. 2012. 361 p.

6. Diagnosis and treatment of musculoskeletal (nonspecific) pain in the lower back: clinical guidelines / Rossiyskoye mezhregional'noye obshchestvo po izucheniyu boli. M., 2021. P. 47.]

7. Degenerative diseases of the spine: clinical guidelines (approved by the Russian Ministry of Health), 2022. [Elektronic resource]. URL: https://cr.minzdrav.gov.ru/recomend/727_1 (Accessed: 22.12.2022).]

8. Lutsik A. A., Sadovoy M. A., Krut'ko A. V., Yepifantsev A. G., Bondarenko G. Yu. Degenerativedystrophic diseases of the spine. Novosibirsk, 2012. P. 264.

9. Barulin A. Ye., Kurushina O. V. Chondroprotectors in the complex therapy of back pain // RMJ. 2013; 30 (21): 1543-1545.

10. Chronic pain in elderly and senile patients clinical guidelines (approved by the Russian Ministry of Health), 2020. [Elektronnyy resurs]. URL: https://cr.minzdrav.gov.ru/recomend/616_1 (data obrashcheniya: 29.12.2022).

11. Gonarthrosis: clinical guidelines (approved by the Russian Ministry of Health), 2021. [Elektronnyy resurs]. URL: https://cr.minzdrav.gov.ru/recomend/667_1 (data obrashcheniya: 25.12.2022).

12. Feklistov A. Yu., Vorob'yeva L. D., Alekseyeva O. G., et al. Results of the noninterventional clinical study "Hummingbird" to assess the efficacy and safety of the use of the drug AMBENE® BIO in patients with primary and secondary osteoarthritis of various localization // RMJ. Meditsinskoye obozreniye. 2022; 6 (8): 1-8. DOI: 10.32364/2587-6821-2022-6-*-1-8.

13. Kalbhen D. A. The influence of NSAIDs on morphology of articular cartilage // Scand J Rheumatol Suppl. 1988; 77: 13-22. DOI: 10.3109/03009748809096930.

14. Yakhno N. N., Kukushkin M. L., Churyukanov M. V., Syrovegin A. V. Results of an open multicenter study "MERIDIAN" to assess the prevalence of 26 pain syndromes in outpatient practice and therapeutic preferences of physicians // Rossiyskiy zhurnal boli. 2012; 3 (36-37): 10-14.]

15. Williamson A., Hoggart B. Pain: a review of three commonly used pain rating scales // Journal of Clinical Nursing. 2005; 14: 798-804.

16. Brooks R., Boye K. S., Slaap B. EQ-5D: a plea for accurate nomenclature // J Patient Rep Outcomes. 2020; 4 (1): 52. DOI: 10.1186/s41687020-00222-9. PMID: 32620995; PMCID: PMC7334333.

17. Aleksandrova Ye. A., Khabibullina A. R., Aistov A. V., et al. Russian population indicators of health-related quality of life calculated using the EQ-5D-3L questionnaire // Sibirskiy nauchnyy meditsinskiy zhurnal. 2020; 3 (40): 99-107. DOI 10.15372/SSMJ20200314.